GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

KYNB · Dec 31, 2024

KYNTRA BIO, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0000950170-25-040280General Corporate

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.90% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-465.88% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

-79.95% · CORE · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

10.65% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

47.47% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

-507.80% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

323.05% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

85.13% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History12 statesHistory building

Sep 30, 20230/7 normalizedLevel 3 Dec 31, 20230/7 normalizedLevel 3 Mar 31, 20240/7 normalizedLevel 3 Jun 30, 20240/7 normalizedLevel 3 Sep 30, 20240/8 normalizedLevel 3 Dec 31, 20240/8 normalizedLevel 3 Mar 31, 20250/8 normalizedLevel 3 Jun 30, 20250/8 normalizedLevel 3 Sep 30, 20256/7 normalizedLevel 3 Dec 31, 20257/8 normalizedLevel 3 Mar 31, 20267/8 normalizedLevel 3 Jun 30, 20264/5 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Increased

Previous: 0.18%
Current: 0.90%
Delta: 0.72%

Cash Generation Decreased

Previous: -18.08%
Current: -465.88%
Delta: -447.80%

Growth Decreased

Previous: 15.45%
Current: -79.95%
Delta: -95.40%

Inventory Pressure Decreased

Previous: 51.66%
Current: 10.65%
Delta: -41.01%

Margin Decreased

Previous: 88.57%
Current: 47.47%
Delta: -41.11%

Profitability Decreased

Previous: -36.21%
Current: -507.80%
Delta: -471.59%

R And D Intensity Increased

Previous: 46.85%
Current: 323.05%
Delta: 276.20%

Sbc Intensity Increased

Previous: 16.59%
Current: 85.13%
Delta: 68.53%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · KYNB Fundamental State →Transitioned To · KYNB Fundamental State →Transitioned To · KYNB CAPEX_INTENSITY_INCREASED →Transitioned To · KYNB CASH_GENERATION_DECREASED →Transitioned To · KYNB GROWTH_DECREASED →Transitioned To · KYNB INVENTORY_PRESSURE_DECREASED →Transitioned To · KYNB MARGIN_DECREASED →Transitioned To · KYNB PROFITABILITY_DECREASED →Transitioned To · KYNB R_AND_D_INTENSITY_INCREASED →Transitioned To · KYNB SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.